Joseph Jordan Romano, D.O.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ultrasonography, Doppler, Transcranial | 11 | 2012 | 290 | 0.960 |
Why?
|
Intracranial Embolism | 8 | 2008 | 210 | 0.740 |
Why?
|
Macrocyclic Compounds | 6 | 2015 | 70 | 0.550 |
Why?
|
Viral Nonstructural Proteins | 6 | 2015 | 241 | 0.550 |
Why?
|
Collateral Circulation | 2 | 2012 | 305 | 0.420 |
Why?
|
Perceptual Disorders | 1 | 2012 | 195 | 0.400 |
Why?
|
Cerebral Revascularization | 1 | 2012 | 227 | 0.380 |
Why?
|
Hepacivirus | 6 | 2015 | 1323 | 0.370 |
Why?
|
Visual Fields | 2 | 2012 | 1027 | 0.330 |
Why?
|
Vasospasm, Intracranial | 2 | 2008 | 207 | 0.330 |
Why?
|
Carotid Stenosis | 4 | 2012 | 812 | 0.330 |
Why?
|
Stroke | 9 | 2012 | 9504 | 0.330 |
Why?
|
Hemianopsia | 1 | 2009 | 125 | 0.320 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2008 | 1056 | 0.310 |
Why?
|
Drug Utilization Review | 1 | 2007 | 259 | 0.290 |
Why?
|
Medical Audit | 1 | 2007 | 480 | 0.290 |
Why?
|
Hemodynamics | 4 | 2012 | 4212 | 0.280 |
Why?
|
Intracranial Aneurysm | 2 | 2008 | 1305 | 0.280 |
Why?
|
Dyslipidemias | 2 | 2011 | 848 | 0.260 |
Why?
|
Emergency Treatment | 1 | 2007 | 511 | 0.240 |
Why?
|
Aneurysm, Ruptured | 1 | 2008 | 481 | 0.230 |
Why?
|
Protease Inhibitors | 3 | 2012 | 785 | 0.230 |
Why?
|
Migraine Disorders | 2 | 2012 | 1574 | 0.220 |
Why?
|
Tissue Plasminogen Activator | 1 | 2007 | 1306 | 0.200 |
Why?
|
Embolism, Fat | 4 | 2007 | 55 | 0.190 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2019 | 34 | 0.190 |
Why?
|
Benzothiazoles | 1 | 2019 | 253 | 0.170 |
Why?
|
Serine Proteinase Inhibitors | 2 | 2010 | 177 | 0.160 |
Why?
|
Articulation Disorders | 1 | 1997 | 12 | 0.160 |
Why?
|
Thrombolytic Therapy | 1 | 2007 | 2158 | 0.160 |
Why?
|
Basilar Artery | 3 | 2005 | 200 | 0.160 |
Why?
|
Fibrinolytic Agents | 1 | 2007 | 2122 | 0.160 |
Why?
|
Cerebral Arteries | 1 | 1999 | 497 | 0.150 |
Why?
|
Brain Ischemia | 6 | 2008 | 3312 | 0.150 |
Why?
|
Academic Medical Centers | 1 | 2007 | 2788 | 0.150 |
Why?
|
Hypoglossal Nerve | 1 | 1997 | 96 | 0.150 |
Why?
|
Vertebrobasilar Insufficiency | 2 | 2008 | 126 | 0.140 |
Why?
|
Phosphates | 1 | 2019 | 780 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2008 | 8997 | 0.140 |
Why?
|
Florida | 3 | 2011 | 434 | 0.130 |
Why?
|
Carrier Proteins | 4 | 2012 | 5098 | 0.130 |
Why?
|
Smoking | 1 | 2011 | 8950 | 0.130 |
Why?
|
Dementia, Multi-Infarct | 2 | 2004 | 12 | 0.120 |
Why?
|
Hypertension | 4 | 2011 | 8270 | 0.120 |
Why?
|
Skull Base Neoplasms | 1 | 1997 | 275 | 0.120 |
Why?
|
Quinazolinones | 1 | 2015 | 223 | 0.120 |
Why?
|
Middle Cerebral Artery | 2 | 2012 | 282 | 0.110 |
Why?
|
Hyperventilation | 1 | 2012 | 77 | 0.110 |
Why?
|
Carotid Artery, Internal, Dissection | 2 | 2004 | 46 | 0.110 |
Why?
|
Quinazolines | 1 | 2019 | 1407 | 0.110 |
Why?
|
Cerebrovascular Circulation | 3 | 2012 | 2740 | 0.110 |
Why?
|
Sulfones | 1 | 2015 | 456 | 0.110 |
Why?
|
Inhalation | 1 | 2012 | 145 | 0.110 |
Why?
|
Visual Acuity | 2 | 2012 | 2488 | 0.110 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2009 | 884 | 0.110 |
Why?
|
Caribbean Region | 1 | 2011 | 171 | 0.100 |
Why?
|
Benzocycloheptenes | 1 | 2009 | 10 | 0.100 |
Why?
|
Embolism | 2 | 2005 | 381 | 0.090 |
Why?
|
Structure-Activity Relationship | 6 | 2012 | 3200 | 0.090 |
Why?
|
Antiviral Agents | 2 | 2015 | 2807 | 0.090 |
Why?
|
Heptanoic Acids | 1 | 2011 | 352 | 0.090 |
Why?
|
Blood Flow Velocity | 4 | 2012 | 1438 | 0.080 |
Why?
|
Labetalol | 1 | 2008 | 31 | 0.080 |
Why?
|
Intracranial Hemorrhage, Hypertensive | 1 | 2008 | 20 | 0.080 |
Why?
|
Glasgow Outcome Scale | 1 | 2008 | 110 | 0.080 |
Why?
|
Vertebral Artery | 2 | 2008 | 204 | 0.080 |
Why?
|
Emergency Service, Hospital | 1 | 2007 | 7495 | 0.080 |
Why?
|
Intracranial Arteriosclerosis | 2 | 2007 | 137 | 0.080 |
Why?
|
Brain Infarction | 2 | 2011 | 299 | 0.080 |
Why?
|
Time and Motion Studies | 1 | 2007 | 155 | 0.080 |
Why?
|
Quinolines | 2 | 2012 | 736 | 0.080 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2007 | 1362 | 0.080 |
Why?
|
Microcirculation | 1 | 2011 | 1293 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2007 | 1339 | 0.070 |
Why?
|
Transportation of Patients | 1 | 2007 | 183 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2007 | 2688 | 0.070 |
Why?
|
Neurotransmitter Agents | 1 | 2009 | 640 | 0.070 |
Why?
|
Vertebral Artery Dissection | 1 | 2005 | 48 | 0.070 |
Why?
|
Cerebrovascular Disorders | 1 | 2012 | 1505 | 0.070 |
Why?
|
Surgical Instruments | 1 | 2008 | 415 | 0.070 |
Why?
|
Cerebral Infarction | 3 | 2005 | 1031 | 0.060 |
Why?
|
Pyrroles | 1 | 2011 | 1172 | 0.060 |
Why?
|
Viral Proteins | 2 | 2010 | 1960 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2011 | 1159 | 0.060 |
Why?
|
Lateral Medullary Syndrome | 1 | 2002 | 9 | 0.060 |
Why?
|
Humans | 35 | 2019 | 715636 | 0.060 |
Why?
|
Dogs | 3 | 2019 | 4043 | 0.060 |
Why?
|
Cyclization | 2 | 2012 | 66 | 0.060 |
Why?
|
Drug Discovery | 3 | 2019 | 1055 | 0.060 |
Why?
|
Image Enhancement | 2 | 2004 | 2978 | 0.060 |
Why?
|
Reflex, Abnormal | 1 | 2002 | 85 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5406 | 0.060 |
Why?
|
Middle Aged | 17 | 2012 | 214618 | 0.060 |
Why?
|
Dominance, Cerebral | 1 | 2004 | 656 | 0.060 |
Why?
|
Subclavian Steal Syndrome | 1 | 2002 | 25 | 0.060 |
Why?
|
Ischemic Attack, Transient | 1 | 2008 | 906 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2007 | 2291 | 0.060 |
Why?
|
Acetazolamide | 1 | 2001 | 96 | 0.050 |
Why?
|
Antihypertensive Agents | 2 | 2011 | 2055 | 0.050 |
Why?
|
Half-Life | 2 | 2012 | 675 | 0.050 |
Why?
|
Cerebral Angiography | 5 | 2008 | 1368 | 0.050 |
Why?
|
Indoles | 1 | 2010 | 1842 | 0.050 |
Why?
|
Secondary Prevention | 1 | 2008 | 1511 | 0.050 |
Why?
|
Vertigo | 1 | 2002 | 188 | 0.050 |
Why?
|
Carotid Artery, Internal | 2 | 2004 | 459 | 0.050 |
Why?
|
Endocarditis | 1 | 2005 | 326 | 0.050 |
Why?
|
Serum Albumin | 1 | 2004 | 675 | 0.050 |
Why?
|
Male | 22 | 2019 | 350156 | 0.050 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2004 | 477 | 0.050 |
Why?
|
Incidence | 3 | 2011 | 20761 | 0.050 |
Why?
|
Triage | 1 | 2007 | 934 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2012 | 2976 | 0.050 |
Why?
|
Rats | 6 | 2015 | 24802 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2009 | 2313 | 0.050 |
Why?
|
Sleep Apnea Syndromes | 1 | 2007 | 869 | 0.050 |
Why?
|
Corpus Callosum | 1 | 2004 | 727 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2002 | 487 | 0.040 |
Why?
|
Benzimidazoles | 1 | 2004 | 876 | 0.040 |
Why?
|
Recovery of Function | 1 | 2009 | 2920 | 0.040 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 1379 | 0.040 |
Why?
|
Arm Injuries | 1 | 1999 | 155 | 0.040 |
Why?
|
Female | 21 | 2012 | 377052 | 0.040 |
Why?
|
Leg Injuries | 1 | 1999 | 187 | 0.040 |
Why?
|
Swine, Miniature | 1 | 2019 | 955 | 0.040 |
Why?
|
Pyridines | 1 | 2009 | 2843 | 0.040 |
Why?
|
Aged | 12 | 2011 | 162383 | 0.040 |
Why?
|
Tongue Diseases | 1 | 1997 | 71 | 0.040 |
Why?
|
Analgesics | 1 | 2004 | 1018 | 0.040 |
Why?
|
Neuroprotective Agents | 1 | 2004 | 993 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3148 | 0.040 |
Why?
|
African Americans | 1 | 2011 | 4991 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14887 | 0.040 |
Why?
|
Deglutition | 1 | 1997 | 202 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2008 | 3683 | 0.030 |
Why?
|
Area Under Curve | 2 | 2010 | 1685 | 0.030 |
Why?
|
Reference Values | 1 | 2002 | 5046 | 0.030 |
Why?
|
Kinetics | 2 | 2012 | 6654 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2012 | 34428 | 0.030 |
Why?
|
Retrospective Studies | 8 | 2012 | 72439 | 0.030 |
Why?
|
Heparin | 1 | 2001 | 1620 | 0.030 |
Why?
|
Animals | 8 | 2019 | 169277 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2007 | 3975 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2007 | 4284 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2019 | 8525 | 0.030 |
Why?
|
Liver | 3 | 2012 | 7588 | 0.030 |
Why?
|
Acute Disease | 3 | 2008 | 7137 | 0.030 |
Why?
|
Models, Molecular | 2 | 2015 | 5465 | 0.030 |
Why?
|
Colitis | 1 | 2019 | 1137 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 9641 | 0.030 |
Why?
|
Brain | 4 | 2012 | 25191 | 0.020 |
Why?
|
Isoindoles | 1 | 2010 | 37 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2008 | 7445 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2015 | 1982 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2012 | 714 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2011 | 62037 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2010 | 233 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2009 | 73 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2010 | 401 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5800 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2010 | 460 | 0.020 |
Why?
|
Time Factors | 2 | 2011 | 40892 | 0.020 |
Why?
|
Echocardiography | 1 | 2002 | 5045 | 0.020 |
Why?
|
Leucine | 1 | 2010 | 569 | 0.020 |
Why?
|
Cyclopropanes | 1 | 2010 | 426 | 0.020 |
Why?
|
Proline | 1 | 2010 | 437 | 0.020 |
Why?
|
Risk Factors | 3 | 2011 | 70927 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2010 | 321 | 0.020 |
Why?
|
Quality of Life | 1 | 2009 | 11719 | 0.020 |
Why?
|
Fractures, Bone | 1 | 1999 | 1877 | 0.020 |
Why?
|
Hospitalization | 1 | 2007 | 9743 | 0.020 |
Why?
|
Adolescent | 3 | 2012 | 85064 | 0.020 |
Why?
|
Carbon Dioxide | 1 | 2012 | 1129 | 0.020 |
Why?
|
Models, Chemical | 1 | 2010 | 634 | 0.020 |
Why?
|
Thioguanine | 1 | 2007 | 52 | 0.020 |
Why?
|
Protein S Deficiency | 1 | 2007 | 18 | 0.020 |
Why?
|
Genotype | 2 | 2012 | 12931 | 0.020 |
Why?
|
Cardiolipins | 1 | 2007 | 83 | 0.020 |
Why?
|
Daunorubicin | 1 | 2007 | 153 | 0.020 |
Why?
|
Femoral Fractures | 2 | 2002 | 369 | 0.020 |
Why?
|
Ischemic Preconditioning | 1 | 2007 | 94 | 0.020 |
Why?
|
Carbamates | 1 | 2008 | 199 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2008 | 39334 | 0.020 |
Why?
|
Snoring | 1 | 2007 | 180 | 0.020 |
Why?
|
Asparaginase | 1 | 2007 | 222 | 0.020 |
Why?
|
Anticoagulants | 1 | 2001 | 4375 | 0.020 |
Why?
|
Molecular Structure | 1 | 2010 | 1944 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2007 | 58288 | 0.020 |
Why?
|
Cytarabine | 1 | 2007 | 688 | 0.020 |
Why?
|
Hepatitis C | 1 | 2015 | 1521 | 0.020 |
Why?
|
Cerebral Hemorrhage | 2 | 2007 | 2586 | 0.020 |
Why?
|
Carrageenan | 1 | 2004 | 68 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1394 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3543 | 0.020 |
Why?
|
Thrombophilia | 1 | 2007 | 312 | 0.020 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2007 | 246 | 0.020 |
Why?
|
Cocaine-Related Disorders | 1 | 2007 | 452 | 0.020 |
Why?
|
Haiti | 1 | 2005 | 541 | 0.020 |
Why?
|
Binding Sites | 1 | 2012 | 6212 | 0.010 |
Why?
|
Blood Pressure | 2 | 2011 | 8534 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2010 | 2431 | 0.010 |
Why?
|
Vasculitis | 1 | 2007 | 515 | 0.010 |
Why?
|
Brain Edema | 1 | 2008 | 618 | 0.010 |
Why?
|
Hematoma | 1 | 2008 | 744 | 0.010 |
Why?
|
Adult | 8 | 2007 | 212228 | 0.010 |
Why?
|
Cell Line | 2 | 2009 | 16574 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2004 | 969 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2954 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2368 | 0.010 |
Why?
|
HIV Infections | 1 | 2007 | 15905 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2007 | 2582 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2004 | 953 | 0.010 |
Why?
|
Sulfonamides | 1 | 2010 | 1923 | 0.010 |
Why?
|
ROC Curve | 1 | 2008 | 3523 | 0.010 |
Why?
|
Thiazoles | 1 | 2008 | 1515 | 0.010 |
Why?
|
Brain Stem | 1 | 2005 | 837 | 0.010 |
Why?
|
Hyperalgesia | 1 | 2004 | 495 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2007 | 1187 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2007 | 1395 | 0.010 |
Why?
|
Migraine with Aura | 1 | 2001 | 199 | 0.010 |
Why?
|
Thalamus | 1 | 2005 | 1012 | 0.010 |
Why?
|
Mutation | 2 | 2015 | 29270 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2004 | 1878 | 0.010 |
Why?
|
Ulna Fractures | 1 | 1999 | 119 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1113 | 0.010 |
Why?
|
Cerebellum | 1 | 2005 | 1479 | 0.010 |
Why?
|
Cerebral Cortex | 2 | 2005 | 5692 | 0.010 |
Why?
|
Posture | 1 | 2002 | 986 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 4903 | 0.010 |
Why?
|
Fibula | 1 | 1999 | 260 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2004 | 1416 | 0.010 |
Why?
|
Tibial Fractures | 1 | 1999 | 245 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2004 | 1455 | 0.010 |
Why?
|
Endarterectomy, Carotid | 1 | 2000 | 527 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2004 | 5034 | 0.010 |
Why?
|
Prospective Studies | 2 | 2011 | 51355 | 0.010 |
Why?
|
Thoracic Surgery | 1 | 2000 | 695 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9812 | 0.010 |
Why?
|
Radius Fractures | 1 | 1999 | 478 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 1999 | 803 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1997 | 20338 | 0.010 |
Why?
|
Lung Diseases | 1 | 2004 | 1904 | 0.010 |
Why?
|
Comorbidity | 1 | 2007 | 10429 | 0.010 |
Why?
|
Mice | 1 | 2019 | 80320 | 0.010 |
Why?
|
Sex Factors | 1 | 2005 | 10660 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 11194 | 0.010 |
Why?
|
Heart Diseases | 1 | 2004 | 2752 | 0.010 |
Why?
|
Calcium | 1 | 2004 | 5798 | 0.010 |
Why?
|
Homeostasis | 1 | 2001 | 3330 | 0.010 |
Why?
|
Body Mass Index | 1 | 2007 | 12546 | 0.010 |
Why?
|
Electroencephalography | 1 | 2004 | 5803 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2007 | 15899 | 0.010 |
Why?
|
Age Factors | 1 | 2005 | 18774 | 0.010 |
Why?
|
Disease Progression | 1 | 2004 | 13219 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11233 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 2001 | 13215 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2007 | 15101 | 0.000 |
Why?
|
Obesity | 1 | 2007 | 12267 | 0.000 |
Why?
|
Child, Preschool | 1 | 2007 | 41184 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2005 | 14438 | 0.000 |
Why?
|
Child | 1 | 2007 | 74418 | 0.000 |
Why?
|